Search
A new pancreatic cancer research center has been created at Memorial Sloan Kettering Cancer Center (MSKCC). The ambitious initiative was established with an initial commitment of $10 million from MSKCC Board member David M. Rubenstein.
As construction began on the Mortimer B. Zuckerman Research Center, SKI adopted new ways to advance therapeutic innovation at Memorial Sloan Kettering.
Nearly every advance in cancer care today is possible because of clinical trials. MSK is breaking down the age barrier that has made it hard for young patients such as Irving Romero Torres to participate in and benefit from clinical research.
For HER2-positive breast cancers, MRI scans that employ machine-learning algorithms can provide more guidance than biopsies alone.
MSK researchers shed light on the signals that determine the fate of embryonic cells.
Neurosurgery research fellow Nelson Moussazadeh was awarded a research grant by Joseph and Nazee Moinian.
New MSK research found patients with non-small cell lung cancer brain metastases may benefit from up-front stereotactic radiosurgery; identified a connection between antibiotic use and autoimmune diseases; and uncovered a previously unknown structural role for messenger RNAs in the cytoplasm of cells.
Thousands of oncology experts from around the world will tune in April 27 and 28 for the American Association for Cancer Research’s (AACR) virtual annual meeting I. The meeting is the first of two virtual sessions, with clinical trial plenary sessions, clinical trial poster sessions, several minisymposia, and more. The AACR virtual annual meeting II will be held June 22 through 24.
The revised scoring system incorporates molecular information related to 31 genes to help predict risk.
Learn how specialists at Memorial Sloan Kettering tattoo highly realistic nipples and areolas on people who have had them removed during surgery for breast cancer.